NURIX THERAPEUTICS, INC. (NRIX) Operating income 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) annual operating income history from SEC filings — each fiscal year as reported.
-$285.7MFY2025 · since FY2019: -$22.2M → -$285.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$285.7M | -34.1% |
| FY2024 | -$213.0M | -37.4% |
| FY2023 | -$155.1M | +15.7% |
| FY2022 | -$183.9M | -56.0% |
| FY2021 | -$117.9M | -81.4% |
| FY2020 | -$65.0M | -192.2% |
| FY2019 | -$22.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice